TY  - JOUR
T1  - THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE
TT  - THE ELEVATION OF LIVER ENZYMES DUE TO HEPATITIS B VACCINE
AU  - Önlen¹, Yusuf
AU  - Savaş, Lütfü
AU  - Özer, Burçin
AU  - İris, Nur Efe
PY  - 2006
DA  - December
JF  - European Journal of General Medicine
PB  - Sağlık Bilimleri Araştırmaları Derneği
WT  - DergiPark
SN  - 1304-3889
SP  - 197
EP  - 200
VL  - 3
IS  - 4
LA  - en
CR  - Grosheide P. Van Damme P. Prevention and control of hepatitis B in the community, WHO Viral Hepatitis Prevantion Board, Communnicable Diseasse Series No.1. 1996, Edegen, Belgium. 2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat 2004; 11(2):97-107
CR  - Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005;2(1):50–7
CR  - Mahoney FC. Update on diagnosis management and prevention of hepatitis B virus infection. Clin Microbiol Rev 1999;12:351-66
CR  - Update: Vaccine Side Effects, Adverse Reactions, Precautions Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45(RR- 12):1-35 and
CR  - Lilic D, Ghosh SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994; 344 (5):1292.
CR  - Ballinger AB, Clark ML. Acute hepatitis B infection after vaccination. Lancet 1994;345:262
CR  - Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. BMJ 2004;329;1080-86
CR  - Koziel MJ, Siddiqui A. Hepatitis B virus and hepatitis Delta virus. In: Mandell GL, Douglas RG, Bennett JE (eds). Principles and practice of infectious disease. 6th ed. Philadelphia: Churchill Livingstone, 2005;1864-90
CR  - Pincus MR, Schaffer JA. Assesment of liver function. In: John Bernard Henry, ed. Clinical Diagnosis and Management By Laboratory Methods. 20th ed.,W.B. Saunders Company, 2001; 253-67
CR  - Prescribing Information. Aventis Pasteur, Lyon, France, 2003, License No 69007
CR  - Csepregi A, Treiber G, Röcken C, Malfertheiner P. Acute exacerbation of autoimmune hepatitis induced by Twinrix. World J Gastroenterol 2005; 11(26):4114-16
CR  - Prescribing Information. GlaxoSmithKline, Rixensart, Belgium, 2003, US License No 1617
CR  - Ballinger AB, Clark ML. Severe acute hepatitis B infection after vaccination. Lancet 1994; 344 (5):12
CR  - Goffin E, Horsmans Y, Cornu C, Geubel A, Pirson Y. Acute hepatitis B infection after vaccination. Lancet 1995; 345:263
CR  - Brezin A, Lautier-Frau M, Hamedani M, Rogeaux O, Hoang PL. Visual loss andeosinophilia hepatitis B vaccine. Lancet 1993;342: 563–4 recombinant
UR  - https://dergipark.org.tr/en/pub/ejgm/issue//72117
L1  - https://dergipark.org.tr/en/download/article-file/61778
ER  -